ENT Devices Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)

ENT Devices Market Size

ENT Devices Market Trends & Growth Drivers

Minimally Invasive Procedures Are Trending in Market

• The biggest trend in the market is minimally invasive ENT procedures, which can be performed at OPDs.
• Their biggest advantages are less invasion, scars, and trauma, cost-effectiveness, shorter wait times and hospitals stays, and quicker recovery.
• Traditional, open procedures involve making sizable incisions in the body to access the parts to be operated upon.
• On the other hand, minimally invasive procedures utilize the natural openings in the nose, ears, and throat to insert slim, flexible endoscopes and other small instruments to visualize and operate on the targeted area.
• One of the minimally invasive ENT procedures becoming rapidly common is balloon sinuplasty, as an alternative to conventional sinus surgery.
• The former does not require the surgeon to access the sinus bone by removing tissue.
• Other such procedures being increasingly performed by ENT specialists are endoscopic sinus surgery, transoral robotic surgery (TORS), endoscopic skull base surgery, and septoplasty.

Growing Prevalence of ENT Diseases

• There is a surging prevalence of ENT diseases across the world, with the rise in non-communicable illnesses, including ENT disorders, which are caused due to the little attention provided to these diseases at the global health level.
• The most widespread complaint experienced among the population is infections in the ear, nose, and throat.
• The frequent infection forces people to get antibiotics prescribed by doctors, and most of them visited hospitals due to ENT problems.
• Sinusitis is the most common medical condition experienced, which is caused by the common cold.
• As per a study, its prevalence in the U.S., Europe, and China is 12.3%, 10.9%, and 13%, respectively.
• The most common symptom of the disease is a stuffy and blocked nose, which may prevent drainage of mucus and block the sinuses.
• Chronic sinusitis is a major factor leading to a large number of surgeries performed in the U.S. every year and affects around 10% of adult populations.

High Cost of ENT Devics Is Biggest Challenge for Market

• The biggest restraint for the ENT devices market is their high costs, especially of advanced variants.
• For instance, endoscopes with high-resolution cameras and 3D vision capabilities cost substantially more than simple ones.
• Similarly, hearing aids can cost up to USD 3,500, thereby being inaccessible for the masses without government subsidies and medical reimbursements.
• Moreover, devices with the IoT technology, which allow data integration with EHRs, are even more expensive, limiting their usage to well-funded medical centers and developed countries.
• The same is the issue with robots for ENT procedures, which have additional costs associated with sensors and upgraded software.

ENT Devices Market Analysis

Product Type Analysis

In 2024, diagnostic devices account for the largest share, of 40%, in the market. This is due to the availability of several products, entry of new players, rise in the elderly population, and surge in the incidence of various ENT disorders. Moreover, the new product launch is further projected to propel the market growth in this category.

Hearing aids are the fastest-growing category, with a CAGR of 8.2% during the forecast period. This is because manufacturers are more focused on launching advanced hearing aids to improve their market presence. For Instance, in February 2022, Oticon A/S launched Oticon Zircon. This product provides new features like users to handle multiple, dynamic sounds from all directions and 360° speech that is clear and balanced even in noisy situations.

The segment has the following categories:

• Diagnostic Devices (Largest Category)
• Surgical Devices
• Hearing Aids (Fastest-Growing Category)
• Visualization Devices
• Others

End User Insights

In 2024, the hospitals category accounts for around 50% revenue share, the largest in the market. Hospitals are the major treatment facilities in the global healthcare system. In the ENT specialty, hospitals play a critical role in care delivery. Often in emerging economies, the hospitals are the sole facilities for performing ENT surgical procedures. Moreover, the rising disposable income, decreasing cost of ENT treatment, improving healthcare infrastructure and spending, and increasing knowledge and awareness about ENT procedures across the world are the key factors driving the market.

Ambulatory centers will have the fastest market growth, during the forecast period. This is attributed to the increasing number of minimally invasive ENT procedures at outpatient centers. Further, these places offer cost-effectiveness over full-fledged hospitals as they are often dedicated to one medical subspecialty. This is why they have specific equipment and limited staff.

These end users are covered in the report:

• Hospitals (Largest Category)
• ENT Clinics
• Ambulatory Centers (Fastest-Growing Category)
• Others

Geographical Analysis

• North America leads the market with a revenue share of 40%, in 2024.
• This is attributed primarily to the improving reimbursement scenario for ENT procedures and the presence of strong market players in this region.
• In addition, the growing awareness about the benefits of ENT devices leads to the increased acceptance of these devices in the region.
• It is also home to most of the established medical device companies, which leads to the wide accessibility and cost-effective of ENT equipment.
• The U.S. and Canada have a favorable medical reimbursement scenario, with encourages people to go even for elective procedures, just as nose jobs for aesthetic purposes.
• The APAC market is expected to grow at a high growth rate, where China and India are major markets in the region.
• The key growth driving forces for the regional market include the presence of a high patient pool with sinusitis, the increase in awareness of these devices, and the rise in the elderly population.
• Governments in regional countries are also raising their spending on healthcare infrastructure to make quality care affordable and available to the masses.
• Additionally, the increasing number of ambulatory centers and small, independent ENT clinics drives the demand for the associated equipment.
• Further, the region is witnessing an increasing prevalence of ENT diseases, which is perhaps the basal driver for the market.
• In India, for instance, hearing loss prevalence is estimated at over 25% of the population, thus presenting a significant healthcare burden and considerably affecting the quality of life.
• Similarly, a study forecasts 2.1 million new cases of head and neck cancer in the country by 2040, which would make ENT devices even more critical.

Mentioned below is the geographical breakdown of the market:

• North America (Largest Regional Market)
  • U.S. (Larger Country Market)
  • Canada (Faster-Growing Country Market)
• Europe
  • U.K.
  • Germany (Largest Country Market)
  • France
  • Spain (Fastest-Growing Country Market)
  • Italy
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China (Largest Country Market)
  • India (Fastest-Growing Country Market)
  • Japan
  • Australia
  • South Korea
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest Country Market)
  • Mexico (Fastest-Growing Country Market)
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest Country Market)
  • South Africa
  • U.A.E. (Fastest-Growing Country Market)
  • Rest of MEA

ENT Devices Market Share

The ENT devices market has a significant degree of fragmentation, which majorly stems from the huge variety of devices available, including some as commo and basic hearing aids, as well as high-tech surgical robots. Hence, different companies dominate different segments of the market, with no single competitor possessing a clear edge. Additionally, while the simple consumer devices, especially hearing aids, often come with relaxed or no safety regulations, those used in clinics and hospitals, especially those with applications in surgery, are strictly regulated by the EMA, FDA, and other government bodies. Additionally, in developing countries, governments offer subsidies to the producers of hearing aids and other consumer ENT devices, which allows small, local companies to proliferate.

ENT Devices Market News

• In July 2024, Oticon A/S began collaborating with Henry Ford Health to conduct clinical research to enhance the outcomes and experiences for people with hearing aids.
• In June 2024, Karl Storz Gmbh & Co. KG received the FDA 510(k) clearance for the Solo+ single-use ear tube device, which has also fulfilled the European Medical Device Regulation mandates.
• In June 2024, Stryker Corporation entered into a partnership with IRCAD North America, a subsidiary of Atrium Health, to advance surgical training and education by offering its surgical platforms and robots to the latter.
• In October 2023, Smith & Nephew plc inaugurated a surgical training and R&D center in Munich.